Elucid Bioimaging Inc.
Plaque detection is just the beginning.
BOSTON, United States · Founded 2015 · $151.5M raised
- Headquarters
- BOSTON, Massachusetts
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- elucidbio.com
- Total Funding
- $151.5M
- Last Round
- $36.5M Venture RoundOct 2025
- Rounds
- 4
About
Elucid is a Boston-based medical tech company offering PlaqueIQ, the first FDA-cleared non-invasive CTA plaque assessment. Cardiovascular precision medicine.
Summary
Elucid Bioimaging Inc. is an Artificial Intelligence company based in BOSTON, United States, founded in 2015. It has raised $151.5M in total across 4 rounds, most recently a $36.5M Venture Round round in Oct 2025. Investors include Elevage Medical Technologies, MedTex Ventures and Global Health Impact Fund.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...